©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPyruvatdehydrogenase deficiency, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Pyruvat dehydrogenase deficiency containing 1 guideline-curated core gene, 23 core candidate genes and altogether 28 curated genes according to the clinical signs

ID
PP2231
Number of genes
24 Accredited laboratory test
Examined sequence length
27,5 kb (Core-/Core-canditate-Genes)
- (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
BOLA3324NM_212552.3AR
DLAT1944NM_001931.5AR
DLD1530NM_000108.5AR
ECHS1873NM_004092.4AR
FBXL41866NM_012160.5AR
GLRX5474NM_016417.3AR
HIBCH1161NM_014362.4AR
IBA571071NM_001010867.4AR
ISCA1415NM_030940.4AR
ISCA2183NM_194279.4AR
LIAS990NM_001278590.2AR
LIPT11122NM_001204830.2AR
LIPT2982NM_001144869.3AR
LONP12688NM_001276479.2AR
NFU1765NM_001002755.4AR
PDHA11173NM_000284.4XL
PDHB1080NM_000925.4AR
PDHX1506NM_003477.3AR
PDP11689NM_001161779.2AR
SLC19A21494NM_006996.3AR
SLC19A31491NM_025243.4AR
SLC25A19963NM_001126121.2AR
SLC25A261100NM_001164796.1AR
TPK1585NM_001042482.2AR

Informations about the disease

Clinical Comment

Rare neurometabolic disorder, wide range of clinical signs, metabolic + neurological components, varying severity; often fatal neonatal lactic acidosis or later-onset neurological disorders; 6 subtypes related to affected subunit of PDH complex, significant clinical overlap: PDHD due to E1-alpha, E1-beta, E2 and E3 deficiency, PDHD due to E3-binding protein deficiency, PDH phosphatase deficiency

 

Synonyms
  • Alias: Ahornsirup-Krankheit, E3-defiziente (DLD)
  • Alias: Dihydro-Lipoamid-Dehydrogenase-Mangel (DLD)
  • Alias: Dihydrolipoamide dehydrogenase deficiency (DLD)
  • 3-hydroxyisobutryl-CoA hydrolase deficiency (HIBCH)
  • Anemia, sideroblastic, 3, pyridoxine-refractory (GLRX5)
  • CODAS (cerebral, ocular, dental, auricular, skeletal anomalies) syndrome (LONP1)
  • Charcot-Marie-Tooth disease, XLD, 6 (PDK3)
  • Combined D-2- + L-2-hydroxyglutaric aciduria (SLC25A1)
  • Combined oxidative phosphorylation deficiency 28 (SLC25A26)
  • Encephalopathy, neonatal severe, with lactic acidosis + brain abnormalities (LIPT2)
  • HARP syndrome (PANK2)
  • Hyperglycinemia, lactic acidosis + seizures (LIAS)
  • Lacticacidemia due to PDX1 deficiency (PDHX)
  • Lipoyltransferase 1 deficiency (LIPT1)
  • Microcephaly, Amish type (SLC24A19)
  • Mitochondrial DNA depletion syndrome, encephalomyopathic type (FBXL4)
  • Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1)
  • Multiple mitochondrial dysfunctions syndrome 1 (NFU1)
  • Multiple mitochondrial dysfunctions syndrome 3 (IBA57)
  • Multiple mitochondrial dysfunctions syndrome 4 (ISCA2)
  • Multiple mitochondrial dysfunctions syndrome 5 (ISCA1)
  • Multiple mitochondrial dysfunctions syndrome 6 (PMPCB)
  • Multiple mitochondrial dysfunctions syndrome with hyperglycinemia (BOLA3)
  • Myasthenic syndrome, congenital, 23, presynaptic (SLC25A1)
  • Neurodegeneration with brain iron accumulation 1 (PANK2)
  • Pyruvate dehydrogenase E1-alpha deficiency (PDHA1)
  • Pyruvate dehydrogenase E1-beta deficiency (PDHB)
  • Pyruvate dehydrogenase E2 deficiency (DLAT)
  • Pyruvate dehydrogenase phosphatase deficiency (PDP1)
  • Spasticity, childhood-onset, with hyperglycinemia (GLRX5)
  • Thiamine metabolism dysfunction syndrome 4, progressive polyneuropathy type (SLC25A19)
  • Thiamine metabolism dysfunction syndrome 5, episodic encephalopathy type (TPK1)
  • Thiamine metabolism dysfunction syndrome, biotin/thiamine-responsive encephalopathy type2 (SLC19A3)
  • Thiamine-responsive megaloblastic anemia syndrome (SLC19A2)
Heredity, heredity patterns etc.
  • AR
  • XL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined